Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Virol ; 85(24): 13457-62, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21976641

ABSTRACT

Candid#1 (Cd1) is an attenuated vaccine strain of Junin virus, the causative agent of Argentine hemorrhagic fever. Although several substitutions are present in Cd1, their importance for attenuation has not been established. We functionally characterized the substitutions present in the Cd1 glycoprotein (GP) and identified F427I in the transmembrane domain of the GP2 subunit as reducing infectivity in a reconstituted viral system. We further showed that this phenotype derives from the destabilization of the GP metastable conformation. Lastly, we identified an increased dependence of Cd1 GP on human transferrin receptor type 1 (hTfR-1) for entry, which may affect the tropism of the attenuated strain in vivo.


Subject(s)
Antigens, CD/metabolism , Junin virus/pathogenicity , Membrane Glycoproteins/metabolism , Receptors, Transferrin/metabolism , Receptors, Virus/metabolism , Viral Envelope Proteins/metabolism , Virulence Factors/metabolism , Virus Internalization , Amino Acid Substitution , Animals , Cell Line , Humans , Junin virus/genetics , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/genetics , Protein Conformation , Vaccines, Attenuated/genetics , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Vaccines/genetics , Virulence Factors/chemistry , Virulence Factors/genetics
2.
Retrovirology ; 7: 51, 2010 Jun 07.
Article in English | MEDLINE | ID: mdl-20529266

ABSTRACT

BACKGROUND: In the absence of the Vpu protein, newly formed HIV-1 particles can remain attached to the surface of human cells due to the action of an interferon-inducible cellular restriction factor, BST-2/tetherin. Tetherin also restricts the release of other enveloped viral particles and is counteracted by a several viral anti-tetherin factors including the HIV-2 Env, SIV Nef and KSHV K5 proteins. RESULTS: We observed that a fraction of tetherin is located at the surface of restricting cells, and that co-expression of both HIV-1 Vpu and HIV-2 Env reduced this population. In addition, Vpu, but not the HIV-2 Env, reduced total cellular levels of tetherin. An additional effect observed for both Vpu and the HIV-2 Env was to redirect tetherin to an intracellular perinuclear compartment that overlapped with markers for the TGN (trans-Golgi network). Sequestration of tetherin in this compartment was independent of tetherin's normal endocytosis trafficking pathway. CONCLUSIONS: Both HIV-1 Vpu and HIV-2 Env redirect tetherin away from the cell surface and sequester the protein in a perinuclear compartment, which likely blocks the action of this cellular restriction factor. Vpu also promotes the degradation of tetherin, suggesting that it uses more than one mechanism to counteract tetherin restriction.


Subject(s)
Antigens, CD/metabolism , HIV Envelope Protein gp160/metabolism , HIV-1/pathogenicity , HIV-2/pathogenicity , Host-Pathogen Interactions , Human Immunodeficiency Virus Proteins/metabolism , Membrane Glycoproteins/metabolism , Protein Interaction Mapping , Viral Regulatory and Accessory Proteins/metabolism , Cell Line , Cell Membrane/chemistry , Endoplasmic Reticulum/chemistry , GPI-Linked Proteins , Humans , Microscopy, Confocal , Microscopy, Fluorescence , Protein Binding
3.
Retrovirology ; 7: 4, 2010 Jan 26.
Article in English | MEDLINE | ID: mdl-20102634

ABSTRACT

BACKGROUND: The gibbon ape leukemia virus (GaLV) Env protein mediates entry into a wide range of human cells and is frequently used to pseudotype retroviral vectors. However, an incompatibility exists between GaLV Env and lentiviral vectors that results in decreased steady-state levels of the mature GaLV Env in cells and prevents its incorporation into lentiviral vector particles. RESULTS: We identified the HIV-1 Vpu protein as the major cause of the depletion in GaLV Env levels that occurs when lentiviral vector components are present. This activity of Vpu targeted the mature (cleaved) form of the GaLV Env that exists within or beyond the trans-Golgi. The activity required two conserved phospho-serines in the cytoplasmic tail of Vpu that are known to recruit beta TrCP, a substrate adaptor for an SCF E3 ubiquitin ligase complex, and could be blocked by mutation of lysine 618 in the GaLV Env tail. Moreover, the Vpu-mediated decrease of GaLV Env levels was inhibited by the lysosomal inhibitor, bafilomycin A1. Interestingly, this activity of Vpu was only observed in the presence of other lentiviral vector components. CONCLUSIONS: Similar to the mechanism whereby Vpu targets BST-2/tetherin for degradation, these findings implicate beta-TrCP-mediated ubiquitination and the endo-lysosomal pathway in the degradation of the GaLV Env by lentiviral vector components. Possibly, the cytoplasmic tail of the GaLV Env contains features that mimic bona fide targets of Vpu, important to HIV-1 replication. Furthermore, the lack of effect of Vpu on GaLV Env in the absence of other HIV-1 proteins, suggests that a more complex interaction may exist between Vpu and its target proteins, with the additional involvement of one or more component(s) of the HIV-1 replication machinery.


Subject(s)
Gene Products, env/antagonists & inhibitors , Gene Products, env/genetics , HIV-1/genetics , Human Immunodeficiency Virus Proteins/genetics , Human Immunodeficiency Virus Proteins/metabolism , Leukemia Virus, Gibbon Ape/genetics , Protein Interaction Mapping , Viral Regulatory and Accessory Proteins/genetics , Viral Regulatory and Accessory Proteins/metabolism , Cell Line , Humans , beta-Transducin Repeat-Containing Proteins/metabolism
4.
J Virol ; 84(2): 1176-82, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19889757

ABSTRACT

Clade B of the New World arenaviruses contains both pathogenic and nonpathogenic members, whose surface glycoproteins (GPs) are characterized by different abilities to use the human transferrin receptor type 1 (hTfR1) protein as a receptor. Using closely related pairs of pathogenic and nonpathogenic viruses, we investigated the determinants of the GP1 subunit that confer these different characteristics. We identified a central region (residues 85 to 221) in the Guanarito virus GP1 that was sufficient to interact with hTfR1, with residues 159 to 221 being essential. The recently solved structure of part of the Machupo virus GP1 suggests an explanation for these requirements.


Subject(s)
Arenaviruses, New World/physiology , Arenaviruses, New World/pathogenicity , Recombinant Fusion Proteins , Viral Envelope Proteins , Amino Acid Sequence , Animals , Arenaviruses, New World/classification , Arenaviruses, New World/genetics , CHO Cells , Cell Line , Cricetinae , Cricetulus , Glycoproteins/chemistry , Glycoproteins/genetics , Glycoproteins/metabolism , Humans , Models, Molecular , Molecular Sequence Data , Receptors, Transferrin/metabolism , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Viral Envelope Proteins/chemistry , Viral Envelope Proteins/genetics , Viral Envelope Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...